SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-016188
Filing Date
2018-11-14
Accepted
2018-11-14 17:10:14
Documents
51
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 626437
2 ex31-1.htm EX-31.1 17794
3 ex31-2.htm EX-31.2 17438
4 ex32-1.htm EX-32.1 7971
5 ex32-2.htm EX-32.2 7726
  Complete submission text file 0001493152-18-016188.txt   2980232

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aitb-20180930.xml EX-101.INS 462160
7 XBRL SCHEMA FILE aitb-20180930.xsd EX-101.SCH 30894
8 XBRL CALCULATION FILE aitb-20180930_cal.xml EX-101.CAL 41535
9 XBRL DEFINITION FILE aitb-20180930_def.xml EX-101.DEF 143590
10 XBRL LABEL FILE aitb-20180930_lab.xml EX-101.LAB 254384
11 XBRL PRESENTATION FILE aitb-20180930_pre.xml EX-101.PRE 204497
Mailing Address 825 EAST GATE BOULEVARD, SUITE 320 GARDEN CITY NY 11530
Business Address 825 EAST GATE BOULEVARD, SUITE 320 GARDEN CITY NY 11530 516-665-8200
AIT Therapeutics, Inc. (Filer) CIK: 0001641631 (see all company filings)

IRS No.: 473812456 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55759 | Film No.: 181185024
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10